Shares of Enovix Co. (NASDAQ:ENVX – Get Free Report) traded up 2.7% on Friday . The company traded as high as $11.90 and last traded at $11.74. 712,217 shares traded hands during trading, a decline of 87% from the average session volume of 5,468,235 shares. The stock had previously closed at $11.43.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on ENVX shares. Oppenheimer reissued an “outperform” rating and issued a $36.00 target price on shares of Enovix in a report on Monday, August 26th. Canaccord Genuity Group increased their price objective on shares of Enovix from $17.00 to $20.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Benchmark began coverage on shares of Enovix in a research note on Monday, July 22nd. They set a “buy” rating and a $25.00 target price on the stock. Piper Sandler reiterated an “overweight” rating and issued a $19.00 price target (down previously from $23.00) on shares of Enovix in a research note on Monday, August 5th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Enovix currently has an average rating of “Buy” and an average target price of $21.33.
Read Our Latest Stock Analysis on Enovix
Enovix Stock Performance
Enovix (NASDAQ:ENVX – Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The company reported ($0.25) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $3.77 million during the quarter, compared to analyst estimates of $3.85 million. Enovix had a negative return on equity of 91.21% and a negative net margin of 1,434.34%. On average, research analysts forecast that Enovix Co. will post -1.21 EPS for the current fiscal year.
Insider Activity at Enovix
In related news, insider Arthi Chakravarthy sold 35,000 shares of the company’s stock in a transaction on Monday, October 14th. The shares were sold at an average price of $13.00, for a total transaction of $455,000.00. Following the sale, the insider now owns 343,305 shares of the company’s stock, valued at $4,462,965. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 17.30% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Enovix
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ENVX. Secure Asset Management LLC purchased a new position in shares of Enovix in the 3rd quarter worth approximately $97,000. Good Life Advisors LLC lifted its position in Enovix by 10.9% in the third quarter. Good Life Advisors LLC now owns 46,213 shares of the company’s stock worth $432,000 after buying an additional 4,524 shares during the last quarter. One Wealth Advisors LLC purchased a new position in Enovix during the third quarter worth $700,000. Magnus Financial Group LLC increased its position in Enovix by 39.2% during the third quarter. Magnus Financial Group LLC now owns 15,655 shares of the company’s stock valued at $146,000 after acquiring an additional 4,405 shares during the last quarter. Finally, Strong Tower Advisory Services purchased a new stake in shares of Enovix in the third quarter valued at $260,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Recommended Stories
- Five stocks we like better than Enovix
- How to Invest in Biotech Stocks
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Stock Analyst Ratings and Canadian Analyst Ratings
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.